# PMV Pharmaceuticals, Inc.: Form SCHEDULE 13D/A, filed Mar 4, 2026

- Company: [PMV Pharmaceuticals, Inc.](/companies/pmvp.md) (CIK 1699382)
- Form: SCHEDULE 13D/A
- Filed: 2026-03-04
- Accepted by EDGAR: Mar 5, 2026, 02:12 ET
- Period: not reported
- Accession: 0000947871-26-000231
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1699382/000094787126000231/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1699382/000094787126000231/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1699382/000094787126000231/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Mar 4, 2026.
Source: SEC EDGAR, the filing index for accession 0000947871-26-000231. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.